STUDIES OF THE OCULAR COMPLICATIONS OF AIDS--CMV RETINITIS RETREATMENT TRIAL

艾滋病眼部并发症的研究--CMV视网膜炎治疗试验

• 批准号: 6122079
• 负责人: BRUCE A BARRON
• 金额: $ 1.12万
• 依托单位: TULANE UNIVERSITY OF LOUISIANA
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-07-19 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6122079
• 关键词: AIDS; chemoprevention; clinical research; clinical trial phase I; combination chemotherapy; cytomegalovirus; drug screening /evaluation; eye disorder chemotherapy; foscarnet; ganciclovir; human subject; human therapy evaluation; medical complication; opportunistic infections; outcomes research; relapse /recurrence; retinitis

Study to compare the safety and efficacy of three therapeutic regimens (high-dose foscarnet, high-dose ganciclovir, or a combination of foscarnet and ganciclovir) for AIDS related CMV retinitis in patients who have been treated with foscarnet or ganciclovir and whose retinitis has progressed or recurred.

研究比较三种治疗方案（高剂量膦甲酸、高剂量更昔洛韦或膦甲酸和更昔洛韦联合治疗）对已接受膦甲酸或更昔洛韦治疗且视网膜炎进展或复发的患者的艾滋病相关CMV视网膜炎的安全性和有效性。